Bayesian Capital Management, LP Argenx Se Transaction History
Bayesian Capital Management, LP
- $788 Million
- Q4 2024
A detailed history of Bayesian Capital Management, LP transactions in Argenx Se stock. As of the latest transaction made, Bayesian Capital Management, LP holds 621 shares of ARGX stock, worth $397,073. This represents 0.05% of its overall portfolio holdings.
Number of Shares
621
Previous 450
38.0%
Holding current value
$397,073
Previous $244,000
56.15%
% of portfolio
0.05%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding ARGX
# of Institutions
424Shares Held
29.4MCall Options Held
338KPut Options Held
347K-
Price T Rowe Associates Inc Baltimore, MD5.52MShares$3.53 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.07MShares$1.96 Billion3.02% of portfolio
-
Janus Henderson Group PLC London, X02.31MShares$1.48 Billion0.76% of portfolio
-
Capital World Investors Los Angeles, CA1.79MShares$1.14 Billion0.17% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$792 Million11.1% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $35.4B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...